Navigation Links
Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
Date:11/6/2008

- Voreloxin Demonstrates Promising Clinical Activity in Patients with

Difficult-to-Treat Cancers -

SOUTH SAN FRANCISCO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) presented data from three clinical trials of the company's lead drug candidate, voreloxin (formerly SNS-595), at the Chemotherapy Foundation Symposium held in New York on November 4-8. Data previously presented from Phase 1 and Phase 1b/2 studies in patients with acute myeloid leukemia (AML) showed that preliminary clinical responses were observed in the relapsed/refractory AML population and the data supports further clinical development for voreloxin both as a single agent and in combination with cytarabine. Preliminary efficacy results previously presented from an ongoing Phase 2 trial demonstrate single agent activity of voreloxin in advanced platinum-resistant ovarian cancer and that the drug is generally well tolerated in this difficult-to-treat patient population.

"We believe that voreloxin has the potential to change the standard of care in AML and platinum-resistant ovarian cancer and look forward to reporting updated results of our AML trials at ASH," said Daniel Swisher, Chief Executive Officer, Sunesis Pharmaceuticals. "Our goal is to advance voreloxin into a pivotal trial in AML by the end of 2009."

Phase 1 and 1b/2 Studies of Voreloxin in AML

Data presented from a completed Phase 1 dose escalation trial of voreloxin as a single agent in acute leukemias (N=73) showed that single agent voreloxin was generally well tolerated, with the most frequently observed dose limited toxicity (DLT) being reversible grade 3/4 oral mucositis. The researchers concluded that single agent a
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
4. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
5. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
7. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
8. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
9. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
10. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
11. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Multiple Sclerosis Drugs Market 2014-2018" report ... a chronic, inflammatory medical condition that results in demyelination, ... because of an abnormal response by the immune system, ... It is a potentially debilitating disease in which the ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, ... (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing ... Company recently changed its fiscal year end to June ... its common stock on a national securities exchange in ... as filed with the United States Securities Exchange Commission ...
(Date:8/29/2014)... ANDOVER, Mass. , Aug. ...  (NYSE: PHG ... at the  European Society of ... company is highlighting the full range of its cardiology solutions ... the care continuum from prevention and ...
Breaking Medicine Technology:Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5
... Life Spine, a medical device company that designs, ... of spine disorders, announced that on Saturday, April 2, ... Technology Training. Over twenty surgical participants ... hands-on cadaver lab training on the safe and effective ...
... Smith & Nephew,s (NYSE: SNN ; ... System, an operative hysteroscopy device for the removal of ... milestone. The TRUCLEAR System is a first-of-its ... hysteroscope with minimally invasive tissue removal capabilities, allowing a ...
Cached Medicine Technology:Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids 2Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids 3Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids 4
(Date:8/31/2014)... 2014 This September, California Library ... Library, celebrates 30 years of changing the lives ... inception, California’s Library Literacy Services has helped nearly ... read and write. , To mark the 30th ... is launching a month-long awareness campaign titled “Together, ...
(Date:8/31/2014)... August 2014: Renal denervation seems to be more successful ... when it includes accessory renal arteries, according to research ... from Germany. , Dr Schmiedel said: "More than one ... defined as blood pressure (BP) greater than 140/90 mmHg. ... (rHTN) and are unable to reduce BP below 140/90 ...
(Date:8/30/2014)... A new method to predict the optimal number ... at ESC Congress today by Dr Benjamin Dahan from ... AEDs located in public places for optimal prevention of ... said: "Out of hospital cardiac arrest is a major ... 50 and 100 per 100 000 in the general ...
(Date:8/30/2014)... Walking-Canes.Net has released several articles related ... can help in making gait problems easier. The new ... website that contains all of the news articles that were ... articles deal with diseases that make walking a problem and ... help in making life easier for the patient. The articles ...
(Date:8/30/2014)... As the economy continues to recover and ... bathrooms and in-home fitness centers, the North American ... interest not only in designing and installing saunas but ... of sauna. Through working with manufacturers across North ... Society provides a strong knowledge base of Finnish traditions ...
Breaking Medicine News(10 mins):Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Renal denervation more successful when it includes accessory arteries 2Health News:New method predicts optimal number and location of AEDs 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2Health News:As Interest in Saunas Increases, the North American Sauna Society Increases Outreach to Provide Education on History, Design, and Culture 2
... , , Consumers Must Have Full ... by Congress , , WASHINGTON, Sept. 22 ... the National Association of Professional Insurance Agents (PIA) is again reminding ... of licensed, professional, independent insurance agents in any reform plan devised ...
... SAN DIEGO, Sept. 22 US Farms, Inc. (Pink Sheets: ... Inc., a Southern California based branding and interactive marketing firm to assist ... consumer brand product line, Aloe365. , , Yan ... are now in a full blown sales and marketing effort with our ...
... 22 /PRNewswire-Asia/ -- The Yanda International Health,City is set to ... The environmentally friendly complex will include facilities offering,state-of-the-art care for ... medical research and training facilities. It,will also include an international ... a model in healthcare services in the 21st century. It ...
... , , , ... rates of childhood obesity and related diseases could mean the next generation ... their parents, NFL Network today kicked off the second year of ... on Manhattan,s Lower East Side. As part of the league,s NFL ...
... NEW YORK, Sept. 22 Reportlinker.com announces that a ... , U.S. Equine Market: Feed, Health Care ... http://www.reportlinker.com/p0148037/US-Equine-Market-Feed-Health-Care-and-Services-for-Horses-The.html , , ... States, which are used primarily for recreation and entertainment. These horses ...
... , , DUBLIN, ... an expanded suite of consulting, analytics and operations services to ... patient safety. , , These ... their hospitals address ongoing economic constraints, improve quality outcomes and ...
Cached Medicine News:Health News:Healthcare Reform Must Include Full Participation by Licensed Professional Insurance Agents 2Health News:US Farms, Inc. Announces Agreement With Rage Marketing, Inc. to Increase Brand Awareness and E-Commerce Product Sales 2Health News:US Farms, Inc. Announces Agreement With Rage Marketing, Inc. to Increase Brand Awareness and E-Commerce Product Sales 3Health News:Yanda International Health City - World Class Healthcare in China 2Health News:Yanda International Health City - World Class Healthcare in China 3Health News:NFL Network Launches 2009 National Keep Gym in School Campaign at New York City Middle School; Effort Will Give More U.S. Students Access to Quality Physical Education 2Health News:NFL Network Launches 2009 National Keep Gym in School Campaign at New York City Middle School; Effort Will Give More U.S. Students Access to Quality Physical Education 3Health News:NFL Network Launches 2009 National Keep Gym in School Campaign at New York City Middle School; Effort Will Give More U.S. Students Access to Quality Physical Education 4Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 2Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 3Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 4Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 5Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 6Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 7Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 8Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 9Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 10Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 11Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 12Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 13Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 14Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 15Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 16Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 17Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 18Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 19Health News:Reportlinker Adds U.S. Equine Market: Feed, Health Care and Services for Horses, The Report 20Health News:Cardinal Health Introduces Expanded Suite of Services to Help Hospital Pharmacies Improve Cost Containment, Workflow, Patient Safety 2Health News:Cardinal Health Introduces Expanded Suite of Services to Help Hospital Pharmacies Improve Cost Containment, Workflow, Patient Safety 3Health News:Cardinal Health Introduces Expanded Suite of Services to Help Hospital Pharmacies Improve Cost Containment, Workflow, Patient Safety 4
Weitlaner retractor, blunt....
Halle bone curette, 8 1/4, oval, malleable shaft, 4 mm wide....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
Ring curette, 4 mm 90 angle....
Medicine Products: